## AI-Driven Advances in Drug Discovery: Mid-2026 Landscape As of June 2026, the integration of artificial intelligence (AI) and computational methods into pharmaceutical research is marked by significant investment, technical innovation, and early translational successes. The field is transitioning from proof-of-concept studies to addressing core challenges in molecular simulation, model interpretability, and scalable automation. While enthusiasm remains high, the industry is also...
Source: https://arxiv.org/abs/2606.26912v1
- rust-lang
- sentinel_research
- quantum-computing
- trinity-research